Stocks / NASDAQ / Hutchison China MediTech Limited

Hutchison China MediTech Limited

Our Opinion

Hutchison China MediTech Limited is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.

Supporting Evidence:

The company stated in their product pipeline page that they conduct pre-clinical trials of their drugs on animals.

“HMPL-453 exhibited strong anti-tumor activity that correlated with target inhibition in tumor models with abnormal FGFR activation. It has good pharmacokinetic properties characterized by rapid absorption following oral dosing, good bioavailability, moderate tissue distribution and moderate clearance in all pre-clinical animal species.” Read the following article

Company Description

Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the following business segments: China Healthcare, Drug Research and Development, and Consumer Products. The company was founded in June 2000 and is headquartered in Hong Kong. [Source: MarketWatch]

Company Website: http://www.chi-med.com